# A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC

> **NCT02590133** · PHASE2 · UNKNOWN · sponsor: **Yun-fei Xia** · enrollment: 328 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Recombinant Human Endostatin Injection (Endostar)
- **DRUG:** Fluorouracil (5-Fu)
- **DRUG:** Nedaplatin

## Key facts

- **NCT ID:** NCT02590133
- **Lead sponsor:** Yun-fei Xia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2018-12
- **Final completion:** 2020-12
- **Target enrollment:** 328 (ESTIMATED)
- **Last updated:** 2017-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02590133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02590133, "A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02590133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*